UPDATE: Brean Murray Carret Raises Price Target on Inhibitex to $26


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


According to Brean Murray Carret, Inhibitex (NASDAQ: INHX) target price is raised to $26.Brean Murray Carret said that Bristol-Myers Squibb and Inhibitex announced an agreement under which BMS will acquire all outstanding shares of Inhibitex for $26 per share or approximately $2.5 billion.Inhibitex closed on Friday at $9.87.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetAnalyst RatingsBrean Murray Carret